Multiple Myeloma News and Research

Latest Multiple Myeloma News and Research

ImmunoCellular Therapeutics presents additional data from its ICT-107 Phase I clinical trial

ImmunoCellular Therapeutics presents additional data from its ICT-107 Phase I clinical trial

ImmunoCellular Therapeutics to present Phase I clinical trial data of ICT-107 vaccine in New Orleans

ImmunoCellular Therapeutics to present Phase I clinical trial data of ICT-107 vaccine in New Orleans

Seattle Genetics reports its third-quarter financial results

Seattle Genetics reports its third-quarter financial results

Celgene announces fiscal 2009 third-quarter results

Celgene announces fiscal 2009 third-quarter results

Alexion Pharmaceuticals reports increased revenues of 11% in third quarter 2009

Alexion Pharmaceuticals reports increased revenues of 11% in third quarter 2009

Millennium commences Vc-R-CHOP Phase II trial for diffuse large B-cell lymphoma

Millennium commences Vc-R-CHOP Phase II trial for diffuse large B-cell lymphoma

ImmunoCellular Therapeutics files a provisional patent application

ImmunoCellular Therapeutics files a provisional patent application

Interim results from Phase 1 CAL-101 trial for chronic lymphocytic leukemia

Interim results from Phase 1 CAL-101 trial for chronic lymphocytic leukemia

Preclinical data of carfilzomib and PR-957 inhibitors to be presented at 2009 ACR/ARHP meeting

Preclinical data of carfilzomib and PR-957 inhibitors to be presented at 2009 ACR/ARHP meeting

Managing Myeloma launches educational activities for multidisciplinary professionals

Managing Myeloma launches educational activities for multidisciplinary professionals

Managing Myeloma website offers scholarship for attending the December 2009 American Society of Hematology Annual Meeting

Managing Myeloma website offers scholarship for attending the December 2009 American Society of Hematology Annual Meeting

Veterans Affairs establishes service-connection benefits for Vietnam Veterans

Veterans Affairs establishes service-connection benefits for Vietnam Veterans

Johnson & Johnson announces financial results for the third quarter of 2009

Johnson & Johnson announces financial results for the third quarter of 2009

Compugen, Bayer Schering Pharma sign collaboration agreement for tumor research

Compugen, Bayer Schering Pharma sign collaboration agreement for tumor research

Onyx Pharmaceuticals signs definitive agreement to acquire Proteolix

Onyx Pharmaceuticals signs definitive agreement to acquire Proteolix

Keryx Biopharmaceuticals commences Phase 2 clinical study evaluating KRX-0401 for Chronic Lymphocytic Leukemia

Keryx Biopharmaceuticals commences Phase 2 clinical study evaluating KRX-0401 for Chronic Lymphocytic Leukemia

pDCs promote growth and survival of malignant myeloma cells

pDCs promote growth and survival of malignant myeloma cells

BioImagene announces launch of the Virtuoso digital pathology solution

BioImagene announces launch of the Virtuoso digital pathology solution

Seattle Genetics discontinues its SeaGen MARINER clinical trial for large B-cell lymphoma

Seattle Genetics discontinues its SeaGen MARINER clinical trial for large B-cell lymphoma

Quest PharmaTech acquires immunotherapeutic antibody products from Paladin Labs

Quest PharmaTech acquires immunotherapeutic antibody products from Paladin Labs